AI firms will be given access to eye scans to see if they can diagnose retinopathy, but all of the data will remain on NHS-owned servers
27 October 2021
Eye scans from 150,000 National Health Service (NHS) patients in the UK will be used to test commercial artificial intelligence tools that could be rolled out to spot the warning signs of diabetic sight loss. But researchers aim to avoid a repeat of previous NHS data-sharing scandals by ensuring that records are anonymised and that AI tests are only run on servers owned by NHS trusts.
Two million people with diabetes in the UK have an annual scan to check for signs of retinopathy, which …